Showing results (481-490 of 1,557) with videos related to

Sort By:
Pageof 156
Therapeutic Advances in Gastroenterology|June 2, 2017
Endoscopic ultrasound-guided hepaticogastrostomy versus percutaneous transhepatic drainage for malignant biliary obstruction after failed endoscopic retrograde cholangiopancreatography: a retrospective expertise-based study from two centersAdrien Sportes, Marine Camus, Michel Greget, et al.
Therapeutic Advances in Gastroenterology|June 2, 2017
Direct oral anticoagulants and digestive bleeding: therapeutic management and preventive measuresDavid Deutsch, Christian Boustière, Emile Ferrari, et al.
Therapeutic Advances in Gastroenterology|May 16, 2018
Minor digestive symptoms and their impact in the general population: a cluster analysis approachDiane L'Heureux-Bouron, Sophie Legrain-Raspaud, Helen R Carruthers, et al.
Therapeutic Advances in Gastroenterology|April 6, 2018
Host-targeting therapies for hepatitis C virus infection: current developments and future applicationsEmilie Crouchet, Florian Wrensch, Catherine Schuster, et al.
Therapeutic Advances in Gastroenterology|September 2, 2016
Magnetic resonance enterography versus capsule endoscopy activity indices for quantification of small bowel inflammation in Crohn's diseaseUri Kopylov, Eyal Klang, Doron Yablecovitch, et al.
Therapeutic Advances in Gastroenterology|September 2, 2016
Serial monitoring of faecal calprotectin for the assessment of endoscopic recurrence in asymptomatic patients after ileocolonic resection for Crohn's disease: a long-term prospective studyTakayuki Yamamoto, Takahiro Shimoyama, Satoru Umegae, et al.
Therapeutic Advances in Gastroenterology|September 2, 2016
Clinical impact of dual red imaging in colorectal endoscopic submucosal dissection: a pilot studyYuki Ninomiya, Shiro Oka, Shinji Tanaka, et al.
Therapeutic Advances in Gastroenterology|September 2, 2016
Closure of gastrointestinal defects with Ovesco clip: long-term results and clinical implicationsGianfranco Donatelli, Fabrizio Cereatti, Parag Dhumane, et al.
Therapeutic Advances in Gastroenterology|September 2, 2016
Experience with biosimilar infliximab (CT-P13) in paediatric patients with inflammatory bowel diseasesJoanna Sieczkowska, Dorota Jarzębicka, Monika Meglicka, et al.
Therapeutic Advances in Gastroenterology|April 7, 2018
Subtherapeutic concentrations of infliximab and adalimumab are associated with increased disease activity in Crohn's diseaseArne Carlsen, Roald Omdal, Kristian Øgreid Leitao, et al.
Pageof 156